#78, Uncovering New Treatments For Severe Mental Illness with David Newton from Akrivia Health

Iktos is an innovative company specializing in the development of artificial intelligence solutions applied to chemical research and new drug design, enabling major productivity gains in upstream pharmaceutical R&D.

DeepLife uses machine learning to curate and annotate single-cell RNA-seq datasets, enabling downstream bioinformatics analysis and target identification.

LabVoice develops a hands-free voice assistant that provides a common human-lab interaction for scientists, enabling voice-assisted workflows and hands-free access to lab software and data.

Ordaōs, a human-enabled machine-driven drug design company leveraging GenAI and AI/ML to design and build mini proteins as therapeutics for biomedical research and drug discovery.

CareJourney provides healthcare analytics solutions that leverage claims data to enable value-based care delivery organizations, hospitals, health plans, and life sciences companies to improve care quality and reduce costs.

Quin Wills, Co-Founder & CSO of Ochre Bio, joins us to discuss their use of deep analysis of liver genetics and precision RNA design to develop new therapies for liver diseases like hepatitis, cirrhosis and liver cancer.

Bluesight's software platform connects data across medication manufacturing, ordering, inventory, dispensing and administration to help hospital pharmacies reduce costs, ensure compliance and improve safety. Kevin shares how this unprecedented visibility enables customers to reduce waste, ensure compliance and detect drug diversion.

Prospection is a healthcare analytics company that converts data into actionable insights by applying machine learning to hundreds of millions of patient histories to predict future health events years in advance.

Akrivia Health provides research data, clinical trial optimization, and molecular characterization for mental health and dementia. We speak with David Newton, COO & Co-Founder of Akrivia Health, about how they use AI to process free text notes into structured data, all while safeguarding patient privacy.

Vim is building an ecosystem to connect healthcare applications and workflows. Co-founder and CEO Oron Afek shares the story behind Vim's evolution into a healthcare "app store" now reaching over 20 million patients.